Dyslipidemia in Chronic Kidney Disease

Dyslipidemia in chronic kidney disease

487 In 1836, Richard Bright commented on the “mil­ ky serum” of patients with (what today would be called) end­stage renal disease (ESRD) – almost certainly the first recognition of hyper­ lipidemia. The relation between heavy proteinu­ ria with dyslipidemia had been noted at the be­ ginning of the 20th century and indeed dyslip­ idemia in patients with nephrotic proteinuria differs in many res...

Managing Dyslipidemia in Chronic Kidney Disease

The incidence of chronic kidney disease (CKD) in the U.S. continues to increase, and now over 10% of the U.S. population has some form of CKD. Although some patients with CKD will ultimately develop renal failure, most patients with CKD will die of cardiovascular disease before dialysis becomes necessary. Patients with CKD have major proatherogenic lipid abnormalities that are treatable with re...

Dyslipidemia Associated with Chronic Kidney Disease

Cardiovascular disease is a major cause of morbidity and mortality in patients with impaired renal function. Dyslipidemia has been established as a well-known traditional risk factor for cardiovascular disease (CVD) in the general population and it is well known that patients with chronic kidney disease (CKD) exhibit significant alterations in lipoprotein metabolism. In this review, the pathoge...

Vitamin deficiencies in chronic kidney disease

Endocrine disorders in chronic kidney disease

Background and Objective: Endocrine disorders are common in patients with chronic kidney disease (CKD). The aim of the present study is reviewing available literature to give a deep understanding of complexities of endocrine disorders in chronic kidney disease. Methods: A narrative reviewing method based on the available literature was approached. Findings: Generally, when renal function de...